TradingView
DEXWireNews
May 4, 2020 9:54 PM

NantKwest, Inc. $5.50 target price 

Description

NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA
Comments
spursvestor
I don’t see where it will have good earnings. What’s driving mechanics
More